Dynamite News Fighting COVID-19: Govt mulling to discontinue Azithromycin on critical patients
The Ministry of Health and Family Welfare is likely to withdraw the use of Azithromycin, which was being administered to severely ill COVID-19 patients in the intensive care units (ICUs), from the combination of Azithromycin and Hydroxychloroquine (HCQ).
New Delhi: The Ministry of Health and Family Welfare is likely to withdraw the use of Azithromycin, which was being administered to severely ill COVID-19 patients in the intensive care units (ICUs), from the combination of Azithromycin and Hydroxychloroquine (HCQ).
According to a government official, the use of Azithromycin was not "much beneficial" on coronavirus patients.
Also Read |
Corona Update: India's COVID-19 tally reaches 8356, death toll at 273
However, the antiviral drug HCQ will be used both on moderate and severe COVID-19 patients.
The Union Health Ministry is likely to amend the existing COVID-19 clinical management guidelines issued by the central government. (ANI)
Also Read |
With A Spike Of 62,212 Cases, India's COVID-19 Tally Reaches 74,32,681